Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

<ul>
<li>GEM Co. is seeking to raise at least USD100m through an A+H listing. J.P. Morgan, CITIC, and CSI are the sponsors.</li>
<li>We look at the company's core segments: new energy materials and critical metal resources.</li>
<li>We discuss our preliminary view on fair value using A-H premium references.</li>
</ul>


GEM Co. is seeking to raise at least USD100m through an A+H listing. J.P. Morgan, CITIC, and CSI are the sponsors.
We look at the company's core segments: new energy materials and critical metal resources.
We discuss our preliminary view on fair value using A-H premium references.


Gem Co Ltd A

GEM Co. A+H Pre-IPO: Early Thought